Nautilus Biotechnology, Inc. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months
Nautilus Biotechnology, Inc. (NAUT) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months of $107.09 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months · last filed 2026-07-28
- 2026-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $107.09M.
- 2026-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $89.60M.
- 2025-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $19.84M.
- 2025-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $50.89M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months |
|---|---|
| 2026-06-30 | $107.09M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $89.60M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $19.84M 10-K · filed 2026-02-26 |
| 2025-09-30 | $50.89M 10-Q · filed 2025-10-28 |
| 2024-12-31 | $87.57M 10-K · filed 2025-02-27 |
| 2024-09-30 | $33.47M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $99.91M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $189.63M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $131.00M 10-K · filed 2025-02-27 |
| 2023-09-30 | $207.46M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $260.58M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $138.71M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $257.86M 10-K · filed 2024-02-28 |
| 2022-09-30 | $306.78M 10-Q · filed 2022-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |